Innovation-oriented approach through “Innovating at the Speed of Life”
First written in FY2016. 10 of 15 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「We have clarified the positioning of digital transformation (DX) as a pillar of innovation. We are exploring digital health companies centered on our US operations and promoting in-house AI development for strategic products.」
The company translated its innovation-driven approach into exploring digital health opportunities originating in the US, in-house AI development, and strengthening capabilities in generative AI, cloud computing, and security. - FY2025AdvancedAnnual report
「Under Delivery, in response to the fact that the adoption rate of minimally invasive treatment remains at 60%, we aim for a world of 100% minimally invasive treatment through high-value-added biological access and delivery for advanced disease treatment. Under Digital, we recognize the difficulty of continuing treatment for chronic diseases as an obstacle to improving patients' long-term quality of life, and aim for a 100% treatment completion rate by harnessing digital technologies.」
The company translated its innovation-driven approach into three directions, Delivery, Digital, and Deviceuticals, and the long-term goals of 100% minimally invasive treatment, a 100% treatment completion rate, and advances in combination products. - FY2022ReframedAnnual report
「Terumo has positioned GS26 as a five-year growth strategy looking beyond the next decade and established “From Devices to Solutions” as its vision. Specifically, we will pursue three “Ds” under this strategy.」
The company reorganized its previous innovation-driven approach into a new strategic framework for developing solutions in three directions: Delivery, Digital, and Deviceuticals. - FY2021AdvancedAnnual report
「In addition to building a strategic portfolio through in-house development and deepening and applying core technologies that are sources of competitive advantage, we are promoting external investment and open innovation, including collaboration with outside parties, to acquire the technologies we need.」
The company translated its innovation-driven approach into multiple initiatives: in-house development, the deepening and application of core technologies, external investment, and open innovation. - FY2020-Q3RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals, viewing new market needs as growth opportunities. - FY2020-Q2RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals. - FY2019-Q3RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals. - FY2019-Q2RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals. - FY2018-Q3RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals. - FY2018-Q2RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its intention to drive innovation through product development that meets the needs of healthcare professionals. - FY2018-Q1RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to state its policy of driving innovation through product development that meets the needs of healthcare professionals. - FY2017-Q3RestatedAnnual report
「We will drive innovation by developing products that meet the needs of healthcare professionals and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its innovation-driven approach through product development that meets the needs of healthcare professionals. - FY2017-Q2RestatedAnnual report
「By viewing these emerging market needs as growth opportunities, the company aims to contribute to society through healthcare, its corporate philosophy, and to achieve sustainable and profitable growth. At the same time, it will drive innovation through product development that meets the needs of healthcare settings and strive to become a company with a strong presence worldwide.」
The company continues to demonstrate its innovation-driven approach through product development that meets the needs of healthcare professionals. - FY2017-Q1RestatedAnnual report
「We will drive innovation by developing products that meet the needs of healthcare professionals and strive to become a company with a strong presence worldwide.」
The company reaffirmed its innovation-driven approach through product development that meets the needs of healthcare professionals. - FY2016First statedAnnual report
「Global vision: “Innovating at the Speed of Life”」
Formulated in January 2015. It sets out the direction of putting patients first, remaining a partner to healthcare professionals, and improving patients' lives and healthcare through innovation.